Frontiers | Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism? | Oncology
ANTIBODY DRUG CONJUGATES - ADC Development Using SMARTag(TM) Technology
Proof of site-specificity of antibody-drug conjugates produced by chemical conjugation technology: AJICAP first generation - ScienceDirect
Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates | Scientific Reports
Kadcycla ADC - Potency Regulatory and Bioprocessing Concerns of ADCs - BioProcess InternationalBioProcess International
BTG-driven conjugation: Antibodies for medicine
Anti-Cancer ADC Drugs: 3 Design Elements, 10 Approved ADCs, Multiple Clinical Trials | Biochempeg
Antibody-drug conjugate - Wikipedia
Antibody–Drug Conjugates: Perspectives and Characterization | Chromatography Online
Strategies and challenges for the next generation of antibody–drug conjugates | Nature Reviews Drug Discovery
On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency | Scientific Reports
ANTIBODY DRUG CONJUGATES - ADC Development Using SMARTag(TM) Technology
Antibody-Drug Conjugates: The New Frontier of Chemotherapy
Antibody-drug conjugates—an emerging class of cancer treatment | British Journal of Cancer
PDF) Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs)
PDF) Analytical methods for physicochemical characterization of antibody drug conjugates
Conjugation methods for ADC development. ADC production using... | Download Scientific Diagram
Pharmaceuticals | Free Full-Text | Antibody–Drug Conjugates: The Last Decade | HTML
PDF) Site-Specific Antibody Conjugation for ADC and Beyond
Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates | Nature Communications
CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001
Cleavable linkers in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing) DOI:10.1039/C8CS00676H
